C7A ICD 10 Code is a non-billable and non-specific code and should not be used to indicate a diagnosis for reimbursement purposes. There are other codes below it with greater level of diagnosis detail. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.

Use additional:
  • code to identify any associated endocrine syndrome, such as:
  • carcinoid syndrome (E34.0)

Type 2 excludes for C7A ICD 10 code
  • malignant pancreatic islet cell tumors (C25.4)
  • Merkel cell carcinoma (C4A.-)

Codes
Possible back-references that may be applicable or related to C7A ICD10 Code:

Present On Admission (POA Exempt)

C7A ICD 10 code is considered exempt from POA reporting

Clinical information about C7A ICD 10 code

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.

NIH: National Cancer Institute

The information in this box was provided by MedlinePlus.gov